Arena Pharmaceuticals Inc. (ARNA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arena Pharmaceuticals Inc...

    NASDAQ: ARNA · Real-Time Price · USD
    99.99
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Arena Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 54K 37K 57K 57K
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 54K 37K 57K 57K
    Operating Income
    		 -625.47M -606.17M -510.49M -453.92M
    Interest Income
    		 738K 1.75M 3.37M 6.11M
    Pretax Income
    		 -616.39M -582.94M -484.07M -422.94M
    Net Income
    		 -617.44M -582.99M -484.11M -422.94M
    Selling & General & Admin
    		 126.2M 126.6M 115.3M 106.3M
    Research & Development
    		 419.51M 409.61M 395.25M 347.74M
    Other Expenses
    		 8.64M n/a n/a n/a
    Operating Expenses
    		 554.35M 536.21M 510.55M 454.04M
    Interest Expense
    		 3.09M 3.18M 3.27M 3.36M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 554.35M 536.21M 510.55M 454.04M
    Income Tax Expense
    		 -402K -1.41M -615K n/a
    Shares Outstanding (Basic)
    		 61.38M 61.14M 60.79M 59.78M
    Shares Outstanding (Diluted)
    		 61.38M 61.14M 60.79M 59.78M
    EPS (Basic)
    		 -10.14 -9.69 -8.17 -7.38
    EPS (Diluted)
    		 -10.14 -9.69 -8.17 -7.38
    EBITDA
    		 -609.48M -575.93M -476.96M -415.7M
    EBIT
    		 -494.89M -461.35M -362.39M -301.17M
    Depreciation & Amortization
    		 3.87M 3.88M 3.88M 3.88M

    Add to Watchlist